Skip to content

Author

S. Sawayanagi

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

36.25 Gy versus 40 Gy in five fractions of curative stereotactic body radiotherapy for prostate cancer: a propensity score-matched analysis

The findings suggest that the 36.25-Gy regimen may be non-inferior to 40 Gy for EFS and may be associated with fewer grade 4 toxicities and better urinary QOL and should be considered hypothesis-generating.

Hideomi Yamashita, Daichi Sugahara, S. Sawayanagi et al. · 0 citations
Open access Sep 2026

Efficacy and safety of risk-adapted modified stereotactic body radiotherapy for lung tumors: a single-institution retrospective study.

Risk-adapted SBRT with increased fractionation demonstrated encouraging LC while maintaining an acceptable toxicity profile for central and ultracentral lung tumors, however, the risk of severe toxicity remains, requiring careful patient selection and optimized OAR dose constraints.

Akiko Oka, Hideomi Yamashita, Y. Miki et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.